InMode (INMD) vs TransMedics Group (TMDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
InMode (INMD) has outperformed TransMedics Group (TMDX) over the past year, losing 6.8% versus a loss of 29.6%. Over five years, TMDX leads with a +205.3% price change compared with -83.2% for INMD. TransMedics Group is the larger company by market cap ($2.73 billion vs $810.5 million), about 3.4 times the size.
On valuation, InMode trades at a lower forward P/E (10.3x vs 35.0x for TransMedics Group).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INMD | TMDX |
|---|---|---|
| Share price | $14.09 | $78.79 |
| Market cap | $810.51M | $2.73B |
| 1-day change | +0.54% | -2.82% |
| YTD return | -4.63% | -33.36% |
| 1-year return | -6.79% | -29.61% |
| 5-year return | -83.20% | +205.35% |
| P/E ratio (TTM) | 11.64 | 20.41 |
| Forward P/E | 10.27 | 34.95 |
| EPS (TTM) | $1.21 | $3.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $605.49M |
| Revenue growth (YoY) | — | +37.13% |
| Net income (latest FY) | — | $190.29M |
| Gross margin | — | 59.92% |
| Operating margin | — | 17.93% |
| Net margin | — | 31.43% |
| 52-week high | $16.74 | $156.00 |
| 52-week low | $12.72 | $60.11 |
| Distance from 52-week high | -15.86% | -49.50% |
| Analyst consensus | none | buy |
| Avg. price target upside | +14.80% | +26.70% |
| Average volume | 521.98K | 815.54K |
| Shares outstanding | 57.54M | 34.68M |
| Employees | 660 | 898 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TransMedics Group is about 3.4 times larger than InMode by market value ($2.73B vs $810.51M).
- INMD has outperformed TMDX by 22.8 percentage points over the past year.
- TransMedics Group trades at a higher earnings multiple (20.4x vs 11.6x trailing P/E).
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
About TransMedics Group
TMDX stock →TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 898 employees
INMD vs TMDX FAQ
Which is bigger, InMode or TransMedics Group?
TransMedics Group (TMDX) is larger, with a market capitalization of $2.73B compared with $810.51M for InMode (INMD).
Which stock has performed better over the past year, INMD or TMDX?
INMD returned -6.79% over the past 12 months, compared with -29.61% for TMDX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INMD or TMDX?
INMD has the lower trailing P/E at 11.6, versus 20.4 for TMDX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are InMode and TransMedics Group in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.